Approval · Notice of Compliance 37571 · 2026
BIPAZEN: Notice of Compliance 37571
Issued May 19, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37571
- Date
- May 19, 2026
- Company
- Kvr Pharmaceuticals Inc.Caledon, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Replacement of a drug product manufacturing site and/or manufacturer involving production. Replacement of a primary container closure system. Update to package insert
- Canadian reference product
- DDAVP INJECTION (Ferring Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BIPAZEN | Not yet assigned | — |
Medicinal ingredients
- DESMOPRESSIN ACETATE 4 MCG per ML